Skip to content

Cobas Core FT4 EIA

by Roche Diagnostic Systems, Inc.

510(k) K932607

Active United States

510(k)

Valid until

No expiry

510(k) clearance is not time-limited

FDA recalls

None found

in data synced 6 Oct 2026

Documents

Trust

Unverified

Registry data, not yet checked by deviCERTS. Source FDA 510(k), synced 6 Oct 2026. What this means

Regulatory status

as of registry sync 6 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK932607 Date24 Jan 1994ClearedStatusActive

Recalls

0 recalls · FDA

No FDA recalls found in the data synced 6 Oct 2026.

Coverage

1 jurisdiction

United States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not covered

United States — FDA 510(k) Active

Specification

510(k)

Full name
Cobas(R) Core FT4 Eia
510(k) Number
FDA Product Code
CEC
Device Class
Class II
Regulation
21 CFR Part 862.1695
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Overview

AI-generated summary, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

The Cobas Core FT4 EIA is an enzyme immunoassay (EIA) device designed for the in vitro quantitative measurement of free thyroxine (FT4) in human serum and plasma. It falls under the category of radioimmunoassay systems, specifically for thyroid hormone analysis, and operates as a diagnostic tool in clinical chemistry laboratories. The assay provides precise FT4 concentration readings, aiding in the diagnosis and monitoring of thyroid disorders such as hypothyroidism or hyperthyroidism.

This device is intended for use on the Cobas Core immunoassay analyzer platform and is supplied as a single-use reagent kit. It requires no special storage conditions beyond standard laboratory refrigeration (2–8°C) and is not intended for reuse. The assay is classified as a Class II medical device under FDA regulations, with clearance granted under 510(k) number K932607. No MRI safety considerations apply, as it is not a magnetic resonance-compatible device. The product code for regulatory purposes is CEC.

Other devices from Roche Diagnostic Systems, Inc.

See all devices from Roche Diagnostic Systems, Inc. →

Questions

AI-generated answers, 1 Oct 2026

Written by a language model from registry data. Not verified by deviCERTS or the manufacturer. The registry data above is the record.

  • What is the Cobas Core FT4 EIA used for?

    The Cobas Core FT4 EIA is an enzyme immunoassay designed for the in vitro quantitative measurement of free thyroxine (FT4) in human serum and plasma. FT4 is a key thyroid hormone, and its precise concentration helps clinicians diagnose and monitor thyroid disorders such as hypothyroidism or hyperthyroidism. By providing accurate FT4 readings, this device supports clinical decision-making in thyroid-related patient care.

  • How is the Cobas Core FT4 EIA supplied, and is it single-use?

    The Cobas Core FT4 EIA is supplied as a single-use reagent kit. This design ensures consistency and reliability in test results, as each kit is intended for one use only. Single-use kits also reduce the risk of cross-contamination and eliminate the need for cleaning or reprocessing between tests, which is critical for maintaining assay accuracy and patient safety.

  • What storage conditions are required for the Cobas Core FT4 EIA?

    The Cobas Core FT4 EIA requires standard laboratory refrigeration between 2°C and 8°C. No additional storage precautions are necessary beyond this temperature range. Proper refrigeration helps preserve the stability and performance of the reagent kit, ensuring reliable assay results when used on the Cobas Core immunoassay analyzer platform.

  • Can the Cobas Core FT4 EIA be reused, or is it intended for single-use only?

    The Cobas Core FT4 EIA is explicitly designed for single-use only. Reusing the reagent kit is not recommended, as it could compromise the integrity of the assay, introduce contamination, or lead to inaccurate FT4 measurements. Single-use kits are engineered to deliver consistent and reliable results while minimizing the risk of cross-contamination between samples.

  • Is the Cobas Core FT4 EIA compatible with MRI environments?

    No, the Cobas Core FT4 EIA is not intended for use in MRI environments. Since it is not a magnetic resonance-compatible device, it should not be exposed to MRI systems or magnetic fields. This device is strictly for use in clinical chemistry laboratories on the Cobas Core immunoassay analyzer platform, where thyroid hormone analysis is performed.